Correlation Between Pfizer and CAPITAL

Can any of the company-specific risk be diversified away by investing in both Pfizer and CAPITAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and CAPITAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and CAPITAL ONE FINL, you can compare the effects of market volatilities on Pfizer and CAPITAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of CAPITAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and CAPITAL.

Diversification Opportunities for Pfizer and CAPITAL

0.79

Correlation Coefficient

Pfizer  CAPITAL

Poor diversification

The 3 months correlation between Pfizer and CAPITAL is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and CAPITAL ONE FINL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CAPITAL ONE FINL and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with CAPITAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CAPITAL ONE FINL has no effect on the direction of Pfizer i.e., Pfizer and CAPITAL go up and down completely randomly.

Pair Corralation between Pfizer and CAPITAL

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the CAPITAL. In addition to that, Pfizer is 11.52 times more volatile than CAPITAL ONE FINL. It trades about -0.08 of its total potential returns per unit of risk. CAPITAL ONE FINL is currently generating about -0.02 per unit of volatility. If you would invest  9,943  in CAPITAL ONE FINL on September 4, 2024 and sell it today you would lose (19.00) from holding CAPITAL ONE FINL or give up 0.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	96.88%
Values	Daily Returns

Pfizer Inc  vs.  CAPITAL ONE FINL

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

CAPITAL ONE FINL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CAPITAL ONE FINL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CAPITAL is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and CAPITAL

The main advantage of trading using opposite Pfizer and CAPITAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, CAPITAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAPITAL will offset losses from the drop in CAPITAL's long position.

The idea behind Pfizer Inc and CAPITAL ONE FINL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.